Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Ascelia Pharma AB

Closing information (x1000 NOK)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 3,751 Less Arrow 1,964 More Arrow 18,981
Earnings before taxes -125,953 Less Arrow -126,314 More Arrow -104,495
EBITDA -138,066 More Arrow -133,525
Total assets 206,747 More Arrow 325,230 Less Arrow 267,530
Current assets 152,168 More Arrow 267,807 Less Arrow 205,669
Current liabilities 35,488 Less Arrow 24,484 Less Arrow 19,236
Equity capital 171,077 More Arrow 300,207 Less Arrow 247,293
- share capital 32,985 More Arrow 33,719 Less Arrow 24,607
Employees (average) 22 Less Arrow 20 Less Arrow 11

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 82.7% More Arrow 92.3% More Arrow 92.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -59.1% More Arrow -38.2% More Arrow -32.0%
Current ratio 428.8% More Arrow 1093.8% Less Arrow 1069.2%
Return on equity (ROE) -73.6% More Arrow -42.1% Less Arrow -42.3%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 2 More Arrow 9 Less Arrow 4
Chg. No. of employees % 10% More Arrow 82% Less Arrow 57%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.